Form 8-K - Current report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 18, 2024

TITAN INTERNATIONAL, INC.

(Exact name of Registrant as specified in its Charter)


Delaware	1-12936	36-3228472
(State of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

1525 Kautz Road, Suite 600, West Chicago, IL 60185

(Address of principal executive offices, including Zip Code)

(630) 377-0486

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common stock, $0.0001 par value	TWI	New York Stock Exchange

Item 1.01 Entry into a Material Definitive Agreement.

On October 18, 2024, Titan International, Inc. (the “Company”) entered into a Stock Repurchase Agreement (the “Stock Repurchase Agreement”) with MHR Capital Partners Master Account LP, a limited partnership organized in Anguilla, British West Indies, MHR Capital Partners (100) LP, a Delaware limited partnership, and MHR Institutional Partners III L.P., a Delaware limited partnership (together, the “MHR Funds”). Pursuant to the Stock Repurchase Agreement, the Company purchased in a privately negotiated transaction from the MHR Funds, and the MHR Funds sold to the Company, an aggregate of 8,005,000 shares (the “MHR Shares”) of the Company’s Common Stock, $0.0001 par value per share (the “Common Stock”), at a per share price of $7.20 per share, for aggregate cash consideration equal to $57,636,000 (the “MHR Repurchase”). The MHR Shares represented approximately 11% of the Company’s outstanding shares of Common Stock immediately prior to the MHR Repurchase and represented all Common Stock owned by the MHR Funds as of October 18, 2024. Certain affiliates of the MHR Funds continue to own Common Stock representing less than 2% of the Company’s outstanding Common Stock.

The MHR Shares have been added to the Company’s treasury shares.

The MHR Repurchase was effected outside of the Company’s existing Share Repurchase Program previously approved by the Company’s Board of Directors on December 16, 2022.

In Amendment No. 10 to the Schedule 13D dated May 13, 2024 and filed with the Securities and Exchange Commission (the “SEC”) by or on behalf of the MHR Funds and certain other affiliated persons on May 14, 2024 (the “2024 MHR 13D”), the reporting persons therein disclosed that they were evaluating various alternatives that may have been available to them with respect to the MHR Shares, including a possible disposition of such shares.

In connection with the MHR Repurchase, the Company’s obligations to provide audit committee observer rights under the Audit Committee Observer Agreement dated September 29, 2016 entered into with the MHR Funds and certain other related persons terminated in accordance with the terms of such agreement.

The cash consideration used to purchase the MHR Shares was funded from a combination of cash on hand and borrowings as described below.

In connection with the MHR Repurchase, the Company borrowed $45 million under the Credit and Security Agreement dated as of February 29, 2024, under which Bank of America serves as agent, to pay for a portion of the consideration provided to the MHR Funds with respect to the MHR Repurchase (the “Credit Facility”). See Item 2.03 below for additional information regarding the Credit Facility.

Dr. Mark H. Rachesky, a director of the Company, is affiliated with the MHR Funds, and pursuant to the 2024 MHR 13D may have been deemed to have sole power to direct the disposition and voting of the MHR Shares, as well as certain additional shares of the Company’s Common Stock. As a result, in connection with the approval of the MHR Repurchase by the Company, the Company’s Audit Committee, as well as the Company’s Board of Directors (with Dr. Rachesky recusing himself), approved the MHR Repurchase. In addition, under the terms of the Indenture dated as of April 22, 2021 with respect to the Company’s $400,000,000 principal amount of 7% Senior Secured Notes due 2028 (the “Indenture”), the Company’s independent directors (as defined in section 303A.02 of the New York Stock Exchange Listed Company Manual) also approved the MHR Repurchase (with Dr. Rachesky recusing himself).

The foregoing description of the Stock Repurchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Stock Repurchase Agreement, a copy of which is filed as Exhibit 10.1 to this report and is incorporated herein by reference.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

As described under Item 1.01 above, on October 18, 2024, in connection with the MHR Repurchase, the Company borrowed $45 million under the Credit Facility.

As described under Item 1.01 of the Company’s Report on Form 8-K dated, and filed with the SEC on, February 29, 2024 (the “2/29/2024 Form 8-K”), amounts available under the Credit Facility are available subject to a borrowing base and are collateralized by accounts receivable and inventory of certain of the Company’s United States and Canadian subsidiaries. The Credit Facility includes a maturity of the earlier of February 29, 2029 or 91 days prior to the maturity of the Company’s 7.00% Senior Secured Notes due 2028. The interest rate of the Credit Facility is generally based on the prevailing SOFR rate, plus an

applicable margin as defined by the Credit Facility. Immediately prior to the MHR Repurchase, the Company had approximately $84 million of availability under the Credit Facility, leaving approximately $39 million available following the MHR Repurchase.

The Company is subject to certain affirmative and negative covenants under the Credit Facility and was in compliance with all of its obligations under the Credit Facility following the draw down that provided a portion of the funds for the MHR Repurchase.

The foregoing description of the Credit Facility does not purport to be complete and is subject to, and qualified in its entirety by reference to, the Credit Facility filed as Exhibit 10.4 to the Company’s 2/29/2024 Form 8-K. Additional information regarding various terms of the Credit Facility is included under “Revolving Credit Facility” in Note 9 to the Company’s Notes to Condensed Consolidated Financial Statements included in the Company’s Form 10-Q for the period ended June 30, 2024 and filed with the SEC on July 31, 2024.

Item 9.01 Financial Statements and Exhibits.

(d) The following exhibits are filed as part of this report:


Exhibit Number			Description
10.1			Stock Repurchase Agreement dated October 18, 2024 by and among Titan International, Inc., a Delaware corporation, MHR Capital Partners Master Account LP, a limited partnership organized in Anguilla, British West Indies, MHR Capital Partners (100) LP, a Delaware limited partnership, and MHR Institutional Partners III L.P., a Delaware limited partnership
99.1			News Release dated October 21, 2024
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			TITAN INTERNATIONAL, INC.
			(Registrant)


Date:	October 21, 2024	By:	/s/ DAVID A. MARTIN
			David A. Martin
			SVP and Chief Financial Officer

STOCK REPURCHASE AGREEMENT

THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of the 18th day of October, 2024, by and between Titan International, Inc., a Delaware corporation (the “Company”), and the entities set forth on Schedule 1 hereto (each a “Seller” and together the “Sellers”).

PRELIMINARY STATEMENTS

A.Sellers currently hold shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), as set forth on Schedule 1 hereto, which share ownership has been reflected by the Sellers and their affiliates on Schedule 13D filings made by and on behalf of such persons with the Securities and Exchange Commission.

B. Sellers 13D filings contemplate the potential disposition of the Shares (as defined below).

C.The Sellers are willing to sell the Shares to the Company in a privately negotiated transaction, and thereafter the Sellers and the Company reached an agreement for the Sellers to sell the Shares to the Company as set forth in this Agreement.

D.The Audit Committee of the Company’s Board of Directors, the Company’s independent directors and the disinterested members of the Company’s Board of Directors have each unanimously approved this Agreement and the transactions contemplated hereby.

AGREEMENT

NOW, THEREFORE, in consideration of the covenants and mutual promises contained herein and other good and valuable consideration, the receipt and legal sufficiency of which are hereby acknowledged, the parties agree as follows:

1.Stock Repurchase. Subject to the terms and conditions of this Agreement, at the Closing (as defined below), the Company is purchasing from Sellers, and Sellers are selling to the Company, for the purchase price of $7.20 per share, the number of shares of Common Stock held by each Seller set forth opposite such Seller’s name on Schedule 1 hereto (the “Shares”) for the aggregate purchase price set forth opposite such Seller’s name on Schedule 1 hereto (the “Repurchase Consideration”), free and clear of all liens, claims, security interests and rights of third parties. Upon payment of the Repurchase Consideration: (x): the Company has determined that the Shares shall cease to be outstanding for any and all purposes, and (y) the Sellers shall no longer have any rights as a holder of the Shares, including any rights that such Seller may have had under the Company’s Certificate of Incorporation or otherwise.

2.Closing.

2.1 Closing. The purchase and sale of the Shares shall take place remotely via the exchange of documents and signatures (or their electronic counterparts) on the date of this Agreement (which time and place are designated as the “Closing”). At the Closing:

(a) the Company and each Seller (by instructions to their applicable securities account institutions through which they hold their Shares) shall instruct The Depository Trust Company (“DTC”) and Computershare Trust Company, N.A. to transfer the Shares held by such Seller and set forth opposite such Seller’s name on Schedule 1 hereto by “ free delivery” to the Company in electronic form in accordance with written instructions to be provided to the Sellers by the Company ; and

(b) The Company shall pay to each Seller the Repurchase Consideration set forth opposite such Seller’s name on Schedule 1 hereto by wire transfer of immediately available funds to the bank

account(s) designated in writing by such Seller prior to the Closing, without and deductions or withholding.

2.2 Simultaneous Deliveries. The delivery of all documents or instruments required to be delivered at the Closing pursuant to this Agreement shall be deemed to occur simultaneously. No delivery shall be effective until such party has received or waived receipt of all the documents that such party is entitled to receive under this Agreement.

3.Representations and Warranties of Seller. Each Seller, severally and not jointly, hereby represents and warrants to the Company as of the date hereof as follows:

3.1 Ownership of Shares; Title. Each Seller is the sole record owner and has direct beneficial ownership of the Shares free and clear of all liens, claims, security interests, options, purchase rights, charges and restrictions (other than restrictions on transfer imposed by applicable securities laws), and is not a party to or bound by any agreement, obligation, commitment, order, judgment or decree which prohibits the execution of this Agreement by such Seller, or which would prohibit or restrict in any manner the transfer of the Shares in the manner contemplated hereby. The Shares represent all of the shares of Common Stock presently held or owned, of record or beneficially, by such Seller or which such Seller has the right to acquire. At the Closing, each Seller shall convey and deliver to the Company good and valid title to all of the Shares, free and clear of all liens, claims, security interests and rights of third parties. Upon payment of the Repurchase Consideration, delivery of the Shares in the name of the Company and crediting of such Shares to the Company’s account on the books of DTC (assuming that neither DTC nor the Company has notice of any “adverse claim” (within the meaning of Section 8-105 of the Uniform Commercial Code then in effect in the State of New York (“UCC”)), then (x) under Section 8-501 of the UCC, the Company will acquire a valid “security entitlement” (as defined in Section 8-102 of the UCC) in respect of such Shares and (y) no action (whether framed in conversion, replevin, constructive trust, equitable lien or other theory) based on an “adverse claim” (within the meaning of Section 8-102 of the UCC) to such Shares may be asserted against the Company with respect to such security entitlement.

3.2 Authority. Each Seller has requisite legal capacity and full power and authority to execute, deliver and perform such Seller’s obligations under this Agreement. This Agreement has been duly and validly executed and delivered by such Seller and constitutes a legal, valid and binding obligation of such Seller, enforceable against such Seller in accordance with its terms, except as the enforceability of such obligation may be limited by bankruptcy, insolvency, reorganization, moratorium, and other similar laws now or hereafter in effect relating to or limiting creditors’ rights generally and general principles of equity relating to the availability of specific performance and injunctive and other forms of equitable relief. The execution and delivery by each Seller of, and the performance by each Seller of its obligations under, this Agreement will not contravene any provision of applicable law, or any agreement or other instrument binding upon such Seller or to which the Shares are subject, or any judgment, order or decree of any governmental body, agency or court having jurisdiction over such Seller, and no consent, approval, authorization or order of, or qualification with, any foreign, federal, state or local governmental body or agency is required for the performance by such Seller of its obligations under this Agreement.

3.3 Litigation. There is no action, suit, proceeding or investigation pending or, to each Seller’s knowledge, currently threatened, that questions the validity of this Agreement, or the right of such Seller to enter into this Agreement or to consummate the transactions contemplated hereby.

3.4 Organization. Each Seller is duly organized, validly existing and in good standing under the laws of its jurisdiction of formation.

3.5 Information. Each Seller is a sophisticated person familiar with transactions similar to those contemplated by this Agreement. Each Seller has received all the information such Seller considers necessary or appropriate for making an informed decision whether to enter into this Agreement and perform the obligations set forth herein. Each Seller hereby represents that it has had an opportunity to ask questions and receive answers from the Company regarding the business, properties, prospects and financial condition of the Company. Each Seller is capable of evaluating the value of the Shares, and hereby confirms that the Company has made no recommendation

- 2 -

as to the advisability of the sale of the Shares by the Sellers and, in particular, each Seller acknowledges that none of the Company, any affiliate of the Company or any agent or other representative of the Company or any broker or any other person representing or purporting to represent the Company (a) is acting as a fiduciary or financial or investment advisor to such Seller, nor (b) has given such Seller any investment advice, opinion or other information on whether the sale of the Shares is prudent. Each Seller hereby acknowledges that, in full understanding of the foregoing, including the possibility that, at the present time or in the future, the Shares could be worth substantially more or less than the Repurchase Consideration, Seller has voluntarily entered into this Agreement and determined to sell the Shares hereunder. Each Seller understands that the Company will rely on the accuracy and truth of the foregoing representations, and each Seller hereby consents to such reliance.

3.6 Independent Counsel and Advisors. Each Seller hereby acknowledges that it has had sufficient time and opportunity in which to consider the terms of this Agreement and to consult with an attorney and tax and financial advisors of its own choosing concerning the terms hereof and any tax consequences of the transactions contemplated hereby. Each Seller has either consulted with such Seller’s own tax advisor regarding such tax consequences or has determined voluntarily not to do so. Further, each Seller agrees that such Seller, and not the Company, shall be responsible for such Seller’s own tax liability that may arise as a result of the transactions contemplated by this Agreement, including all foreign, federal, state and local income, capital gain, payroll, employment, transfer and other taxes, and any withholding taxes or related obligations (including interest and penalties) incurred with respect to payments made to such Seller.

3.7 No Brokers or Finders. Each Seller hereby confirms that such Seller has not incurred and will not incur, directly or indirectly, as a result of any action taken or permitted to be taken by or on behalf of such Seller, any liability for brokerage or finders’ fees or agents’ commissions or similar charges in connection with the execution and performance of the transactions contemplated by this Agreement.

3.8 Compliance with OFAC. Neither any of the Sellers, nor Dr. Mark Rachesky, nor, to the knowledge of the Sellers, any director, officer, agent, employee or affiliate of any of the Sellers or any of their subsidiaries, is an individual or entity (a “Seller OFAC Person”), or is owned or controlled by a Seller OFAC Person, that is currently the subject or target of any sanctions administered or enforced by the U.S. government (including, without limitation, the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”) or the U.S. Department of State and including, without limitation, the designation as a “specially designated national” or “blocked person”), the Canadian government, the United Nations Security Council, the European Union, Her Majesty's Treasury, or other relevant sanctions authority (collectively, “Sanctions”), nor is any Seller or any of their subsidiaries located, organized or resident in a country or territory that is the subject or the target of Sanctions, including, without limitation, the Crimea Region, the so-called Donetsk People's Republic, the so-called Luhansk People's Republic, Cuba, Iran, North Korea, Russia and Syria (each, a “Sanctioned Country”); and none of the Sellers will directly or indirectly use the Repurchase Consideration, or lend, contribute or otherwise make available the proceeds from such Repurchase Consideration, to any subsidiary, joint venture partner or other Seller OFAC Person (i) to fund or facilitate any activities of or business with any Seller OFAC Person that, at the time of such funding or facilitation, is the subject or the target of Sanctions, (ii) to fund or facilitate any activities or business in any Sanctioned Country in violation of Sanctions or (iii) in any other manner that will result in a violation by any Seller OFAC Person of Sanctions, any law relating to bribery or corruption (including the U.S. Foreign Corrupt Practices Act of 1977, the UK Bribery Act of 2010, the Corruption of Foreign Public Officials Act (Canada) and the Patriot Act), any law relating to terrorism or money laundering (including the Patriot Act and Canadian anti-money laundering legislation) or any other applicable laws.

4.Representations and Warranties of the Company. The Company represents and warrants to each Seller as of the date hereof as follows:

4.1 Authority. The Company has all requisite corporate power and authority to execute, deliver and perform its obligations under this Agreement. This Agreement has been duly and validly executed and delivered by the Company and constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as the enforceability of such obligation may be limited by bankruptcy, insolvency, reorganization, moratorium, and other similar laws now or hereafter in effect relating to or limiting

- 3 -

creditors’ rights generally and general principles of equity relating to the availability of specific performance and injunctive and other forms of equitable relief. The execution and delivery by the Company of, and the performance by the Company of its obligations under, this Agreement will not result in a violation of, or default under, its Certificate of Incorporation or Bylaws, applicable law, or, to the Company’s knowledge, any judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company.

4.2 No Other Representations or Warranties. Except for the representations and warranties contained in this Section 4, neither the Company nor any other person on behalf of the Company, has made any other express or implied representation or warranty, either written or oral, including, but not limited to, whether the Repurchase Consideration represents the fair market value of the Shares.

4.3 No Brokers or Finders. The Company hereby confirms that it has not incurred and will not incur, directly or indirectly, as a result of any action taken or permitted to be taken by it or on its behalf, any liability for brokerage or finders’ fees or agents’ commissions or similar charges in connection with the execution and performance of the transactions contemplated by this Agreement.

5.Miscellaneous.

5.1 Expenses. All costs and expense incurred in connection with the negotiation, execution, delivery and performance of this Agreement (including attorneys’ fees) and the transactions contemplated hereby shall be paid by the party incurring the expenses.

5.2 Assignment. Neither this Agreement nor any rights or duties of a party hereto may be assigned by such party, in whole or in part, without (a) the prior written consent of the Company in the case of any assignment by any Seller; or (b) the prior written consent of each Seller in the case of an assignment by the Company.

5.3 Successors and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective executors, administrators, heirs, permitted successors and permitted assigns of the parties. Except as expressly provided herein, nothing in this Agreement, express or implied, is intended to confer upon any party, other than the parties hereto, any rights, remedies, obligations or liabilities under or by reason of this Agreement.

5.5 Governing Law. This Agreement shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Agreement shall be governed by, the internal laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware. Each of the Company and each Seller hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts governing DuPage County, Illinois, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH OF THE COMPANY AND EACH SELLER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

5.6 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. A signed copy of this Agreement delivered by email or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

5.7 Headings. The headings of the sections of this Agreement are for convenience only and shall not by themselves determine the interpretation of this Agreement.

- 4 -

5.8 Notices. All notices, instructions and other communications hereunder or in connection herewith shall be in writing, and shall be sent to the parties at the following addresses:

To each of Sellers, at the addresses set forth on Schedule 1 hereto; and

To the Company at:

1525 Kautz Road, Suite 600,

West Chicago, IL 60185

Attn: David Martin

Email: david.martin@titan-intl.com

With a copy (which shall not constitute notice) to:

Thompson Coburn LLP

505 North 7th Street

St. Louis, MO 63101

Attn: Thomas Litz, Esq.

All such notices, instructions and communications shall be (a) delivered personally, (b) sent by registered or certified mail, return receipt requested, postage prepaid, (c) sent via a reputable nationwide overnight courier service or (d) sent by electronic mail. Any such notice, instruction or communication shall be deemed to have been delivered upon receipt if delivered by hand, three business days after it is sent by registered or certified mail, return receipt requested, postage prepaid, one business day after it is sent via a reputable nationwide overnight courier service or when transmitted with electronic confirmation of receipt, if transmitted by electronic mail (if such transmission is made during regular business hours of the recipient on a business day; or otherwise, on the next business day following such transmission). Any party may change its address by giving notice to the other parties in the manner provided above.

5.9 Amendment or Waiver of Agreement. The provisions of this Agreement may not be amended or waived except by a written instrument signed by the Company and each Seller.

5.10 Legal Action and Fees. In the event of any controversy, claim or dispute between the parties hereto arising out of or relating to this Agreement, the prevailing party shall be entitled to recovery from the other party of its reasonable expenses, including attorneys’ fees.

5.11 Entire Agreement. The terms of this Agreement and other documents and instruments referenced herein are intended by the parties as a final expression of their agreement with respect to the subject matter hereof and thereof and may not be contradicted by evidence of any prior or contemporaneous agreement. The parties further intend that this Agreement supersedes any prior agreements and understandings, written or oral, with respect to the Shares (which prior agreements if still in effect as of the date hereof shall be deemed terminated as of the Closing), including but not limited to that certain Audit Committee Observer Agreement dated as of September 29, 2016 by and among the Company and Michael Sirignano, Mark H. Rachesky, MHR Holdings LLC, MHR Fund Management LLC, MHR Institutional Advisors III LLC, MHR Advisors LLC, MHRC LLC, MHR Institutional Partners III LP, MHR Capital Master Account LP and MHR Capital Partners (100) LP and that certain Agreement dated as of February 26, 2016 and thereafter amended on February 25, 2019, by and among the Company, MHR Institutional Partners III LP, MHR Capital Partners Master Account LP, MHR Capital Partners (100) LP, MHR Institutional Advisors III LLC, MHR Advisors LLC, MHRC LLC, MHR Fund Management LLC, MHR Holdings LLC and Mark H. Rachesky.

- 5 -

5.12 Representation by Legal Counsel. Each party is a sophisticated person or entity that was advised by experienced legal counsel and other advisors in the negotiation and preparation of this Agreement. As a result, neither this Agreement or any provision herein shall be interpreted in favor of or against a party because such party or its legal counsel drafted this Agreement or such provision.

5.13 Survival. The representations and warranties herein shall survive the Closing.

5.14 Disclosure. Each party hereto will use commercially reasonable efforts to provide the other with an opportunity to review and comment upon any public statement or disclosure regarding this Agreement and the transactions contemplated herein prior to making any such statement or disclosure regarding this Agreement and the transactions contemplated herein prior to making any such statement or disclosure, subject to each party’s obligations under law.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of the date first set forth above.



TITAN INTERNATIONAL, INC., a Delaware corporation

By:						/s/ Paul Reitz
Name:						Paul Reitz
Title:						CEO/President



MHR CAPITAL PARTNERS MASTER ACCOUNT LP, a limited partnership organized in Anguilla, British West Indies
By:	MHR Advisors LLC, its general partner
By:		/s/ Janet Yeung
Name:		Janet Yeung
Title:		Authorized Signatory

MHR CAPITAL PARTNERS (100) LP, a Delaware limited partnership
By:	MHR Advisors LLC, its general partner
By:		/s/ Janet Yeung
Name:		Janet Yeung
Title:		Authorized Signatory
MHR INSTITUTIONAL PARTNERS III L.P., a Delaware limited partnership By MHR Institutional Advisors III LLC, its general partner
By:		/s/ Janet Yeung

- 6 -


Name:						Janet Yeung
Title:						Authorized Signatory

[Signature Page to Stock Repurchase Agreement]

- 7 -

Schedule 1

Sellers


Name	Address	Number of Shares of Company Common Stock Held	Repurchase Consideration
MHR Capital Partners Master Account LP, a limited partnership organized in Anguilla, British West Indies	c/o MHR Fund Management LLLC, 1345 Avenue of the Americas, 42nd Floor, New York, NY 10105 Email: jyeung@mhrfund.com	715,138	$5,148,993.60
MHR Capital Partners (100) LP, a Delaware limited partnership	c/o MHR Fund Management, LLC 1345 Avenue of the Amercas, 42nd Floor, New York, NY 10105 Email: jyeung@mhrfund.com	89,435	$643,932.00
MHR Institutional Partners III L.P., a Delaware limited partnership	c/o MHR Fund Management LLLC, 1345 Avenue of the Americas, 42nd Floor, New York, NY 10105 Email: jyeung@mhrfund.com	7,200,427	$51,843,074.40
Total		8,005,000	$57,636,000

- 8 -

Titan International, Inc. Repurchases 8.0 Million Shares from MHR Fund Management

Oct 21, 2024

CHICAGO, Oct. 21, 2024 /PRNewswire/ -- Titan International, Inc. announced it completed the repurchase of 8.0 million shares of common stock from MHR Fund Management for $57.6 million ($7.20 per share) in cash. MHR Fund Management is led by Mark Rachesky, who has been a member of Titan International Inc’s Board of Directors since 2014.

Paul Reitz, Titan’s President and Chief Executive Officer, stated, “Titan’s Board of Directors was presented with an opportunity for our shareholders to repurchase 8.0 million shares (11% of outstanding shares) at $7.20 per share from MHR Fund Management. Titan’s balance sheet is in a healthy position prior to this transaction with approximately $225 million in cash and a current net debt to EBITDA ratio of 1.9 times using trailing twelve months financial results. Our Board of Directors and management team believe that the long-term prospects for Titan are strong, making this a sound investment of capital.”

The transaction was approved by Titan’s Board of Directors, with no impact on the preexisting share repurchase authorization, and funded using a combination of availability on the Company’s revolving credit facility and available cash.

Titan Chairman Maurice Taylor, Jr. added “In my 50 plus years in the business, I never have seen a better future for Titan. Paul Reitz and his team are setting Titan up to grow. No other company in the world has the range and manufacturing capacity of wheels and tires that Titan does. The test of super-sized Titan LSW single wheels and tires has proven that crop yields increased around 5% and fuel savings up to 1/3 gallon per acre versus dual standard tire setups. Farmers are ordering new equipment with these new LSW super-singles or changing out current equipment. It’s taken a long time to get the attention of end-users but, now it’s there. It’s really great to see Titan as the leader of wheels and tires in the world of farming and I believe the future will be good for the Company.”

Taylor concluded “The US Army has used super-singles on trucks for over 15 years, and Titan will soon be building wheels and tires in the LSW design for them to test. The Army is looking at newly-designed trucks, with production levels of 100,000 over ten years. That is a significant amount of wheels and tires, and I’m excited about the opportunity that presents for Titan!”

About Titan: Titan International, Inc. (NYSE: TWI) is a leading global manufacturer of off-highway wheels, tires, assemblies, and undercarriage products. Headquartered in West Chicago, Illinois, the company globally produces a broad range of products to meet the specifications of original equipment manufacturers (OEMs) and aftermarket customers in the agricultural, earthmoving/construction, and consumer markets. For more information, visit www.titan-intl.com.

Safe Harbor Statement

This press release contains forward-looking statements. These forward-looking statements are covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “anticipate,” “plan,” “would,” “could,” “potential,” “may,” “will,” and other similar expressions are intended to identify forward-looking statements, which are generally not historical in nature. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Although we believe the assumptions upon which these forward-looking statements are based are reasonable, these assumptions are subject to significant risks and uncertainties, and are subject to change based on various factors, some of which are beyond Titan International, Inc.'s control. As a result, any of these assumptions could prove to be inaccurate and the forward-looking statements based on these assumptions could be incorrect. The matters discussed in these forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results and trends to differ materially from those made, projected, or implied in or by the forward-looking statements depending on a variety of uncertainties or other factors including, but not limited to, the effect of the COVID-19 pandemic on our operations and financial performance; the effect of a recession on the Company and its customers and suppliers; changes in the Company’s end-user markets into which the Company sells its products as a result of domestic and world economic or regulatory influences or otherwise; changes in the marketplace, including new products and pricing changes by the Company’s competitors; the Company's ability to maintain satisfactory labor relations; unfavorable outcomes of legal proceedings; the Company's ability to comply with current or future regulations applicable to the Company's business and the industry in which it competes or any actions taken or orders issued by regulatory authorities; availability and price of raw materials; levels of operating efficiencies; the effects of the Company's indebtedness and its compliance with the terms thereof; changes in the interest rate environment and their effects on the Company's outstanding indebtedness; unfavorable product liability and warranty claims; actions of domestic and foreign governments, including the imposition of additional tariffs; geopolitical and economic uncertainties relating to the countries in which the Company operates or does business; risks associated with acquisitions, including difficulty in integrating operations and personnel, disruption of ongoing business, and increased expenses; results of investments; the effects of potential processes to explore various strategic transactions, including potential dispositions; fluctuations in currency translations; risks associated with environmental laws and regulations; risks relating to our manufacturing facilities, including that any of our material facilities may become inoperable; risks relating to financial reporting, internal controls, tax accounting, and information systems; and the other risks and factors detailed in the Company’s periodic reports filed with the Securities and Exchange Commission, including the disclosures under "Risk Factors" in those reports. These forward-looking statements are made only as of the date hereof. The Company cautions that any forward-looking statements included in this press release are subject to a number of risks and uncertainties, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events, or for any other reason, except as required by law.

8-K Document and Entity Information Document	Oct. 18, 2024
Document Information [Line Items]
Document Type	8-K
Document Period End Date	Oct. 18, 2024
Entity Registrant Name	TITAN INTERNATIONAL, INC.
Entity Incorporation, State or Country Code	DE
Entity File Number	1-12936
Entity Tax Identification Number	36-3228472
Entity Address, Address Line One	1525 Kautz Road, Suite 600
Entity Address, City or Town	West Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60185
City Area Code	(630)
Local Phone Number	377-0486
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Common stock, $0.0001 par value
Trading Symbol	TWI
Security Exchange Name	NYSE
Entity Central Index Key	0000899751
Amendment Flag	false